MODULATION OF THE INHIBITORY EFFECT OF PHENYLETHYLAMINE ON SPONTANEOUS MOTOR-ACTIVITY IN MICE BY CPP-(+ -)-3-(2-CARBOXYPIPERAZIN-4-YL)-PROPYL-1-PHOSPHONIC ACID/
Ip. Lapin et A. Yuwiler, MODULATION OF THE INHIBITORY EFFECT OF PHENYLETHYLAMINE ON SPONTANEOUS MOTOR-ACTIVITY IN MICE BY CPP-(+ -)-3-(2-CARBOXYPIPERAZIN-4-YL)-PROPYL-1-PHOSPHONIC ACID/, Pharmacology, biochemistry and behavior, 56(2), 1997, pp. 199-204
beta-phenyl-ethylamine (PEA) at dose of 50 mg/kg inhibits spontaneous
motor activity in mice. -)-3-(2-Carboxypiperazin-4-yl)-propyl-1-phosph
onic acid, a selective and competitive antagonist of N-methyl-D-aspart
ate (NMDA) receptors, in doses of 0.2-10 mg/kg dose-dependently antago
nizes this inhibitory effect of PEA. This effect of CPP appeared to be
selective because the inhibitory action of PEA was not altered by pre
treament with noncompetitive antagonists of NMDA receptors, such as di
zocilpine (MK-801), phencyclidine (PCP), 1-phenylcyclohexylamine (PCA)
or by antagonists of other behavioral effects of PEA such as haloperi
dol, baclofen and phenibut (beta-phenyl-GABA). CPP failed to antagoniz
e the inhibitory effect of other tested drugs such as diazepam, halope
ridol, baclofen and phenibut. Intracerebroventricularly administered N
MDA (0.2 mu M), an agonist of NMDA receptors, suppressed the antagonis
tic effects of CPP against PEA. This suggests that anti-PEA effect of
CPP is related to NMDA receptors. Anti-PEA effect of CPP is not due to
accelerated deamination of PEA in CPP-treated mice. When small doses
of PEA (5 and 10 mg/kg) and CPP (0.2 and 1 mg/kg) were used, the syner
gism of two drugs was observed. CPP (1 mg/kg) and deprenyl (0.5 mg/kg)
, an inhibitor monoamine oxidase of B type (MAO-B), had additive effec
ts on PEA-induced inhibition of locomotion. This effect was not associ
ated with any further inhibition of activity of brain MAO-B (over the
inhibition induced by deprenyl alone-by 65%) under high (80 mu M) or l
ow (4.3 mu M) concentration of PEA as a substrate in the medium. Mecha
nism of the interaction of CPP and PEA, two drugs belonging to differe
nt groups of biologically active compounds, deserves further studies.
Copyright (C) 1997 Elsevier Science Inc.